Skip to main content
Caplight Logo









Sanoculis

Sanoculis

Private
IsraelHealthcare & Life Scienceshttps://sanoculis.com/

Last Round

Series C

Jul 28, 2022

Est. Valuation

$52M

Total Funding Raised

$26M

Company Overview

Sanoculis is an ophthalmic medical device company that develops innovative, stent-free, and minimally invasive surgical solutions for the treatment of glaucoma.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

glaucoma surgeryminimally invasive glaucoma surgeryMIGSstentless glaucoma surgeryophthalmic medical deviceintraocular pressure reductionsurgical drainage systemMIMSMINTeye surgery toolstrabeculectomy alternativesurgical trephinationophthalmology equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sanoculis Comparables

Compare Sanoculis with similar companies based on industry and business-model similarity.

Sanoculis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iSTAR Medical
82%
Sight Sciences
81%
ViaLase
80%

Sanoculis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 28, 2022
Series BSep 11, 2019

Sanoculis Investors

Notable investors and investment history

Sanoculis investors
InvestorRounds
Infinity GroupSeries C
EckuitySeries C
T3 Technion Technology TransferVC Round
HCS Capital PartnersSeries B

Sanoculis Filings

Explore SEC and related filing metadata, where available.

Sanoculis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sanoculis's valuation, stock price, and market status.

Is Sanoculis a public or private company?

Sanoculis is a private company.

What is the current stock price of Sanoculis?

Sanoculis is a private company with no public stock price. No recent secondary market data is available.

How much is Sanoculis worth (valuation)?

Sanoculis's valuation is estimated at $49.0M based on funding round data.

Can I buy Sanoculis stock?

Sanoculis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sanoculis's last funding round?

Sanoculis's most recent funding round was Series C on July 28, 2022.

Who are the main investors in Sanoculis?

Key investors in Sanoculis include Infinity Group, Eckuity, HCS Capital Partners.

Will Sanoculis IPO soon?

No public IPO plans have been announced for Sanoculis.

How can I track Sanoculis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sanoculis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range9
Year Founded2012
Last FundingJul 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?